| Code | CSB-MP011753HU(F2) |
| Abbreviation | Recombinant Human INSR protein, partial (Active) |
| MSDS | |
| Size | $190 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
Insulin receptor signaling governs glucose homeostasis and metabolic regulation, making INSR a central target in diabetes research and therapeutic antibody development. This mammalian-expressed construct spanning residues 28–944 of the short isoform captures the complete extracellular ligand-binding architecture, ensuring native glycosylation and disulfide bond formation critical for physiological receptor conformation. Functional ELISA validation demonstrates robust antibody binding with an EC50 of 3.216–3.830 ng/mL, confirming that the protein retains epitope accessibility and structural integrity suitable for therapeutic antibody epitope mapping, competitive inhibition screening, and blocking antibody validation assays. Purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg align with standards expected in surface plasmon resonance affinity characterization, biolayer interferometry kinetic studies, and ligand-receptor interaction profiling for small-molecule or biologic inhibitor discovery programs targeting metabolic disease pathways.
There are currently no reviews for this product.